Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Claritev (CTEV) EBT (2019 - 2026)

Claritev has reported EBT over the past 7 years, most recently at -$106.9 million for Q4 2025.

  • For Q4 2025, EBT rose 42.56% year-over-year to -$106.9 million; the TTM value through Dec 2025 reached -$373.1 million, up 78.93%, while the annual FY2025 figure was -$373.1 million, 78.93% up from the prior year.
  • EBT for Q4 2025 was -$106.9 million at Claritev, down from -$93.4 million in the prior quarter.
  • Over five years, EBT peaked at $97.8 million in Q3 2021 and troughed at -$648.0 million in Q4 2022.
  • A 5-year average of -$133.8 million and a median of -$50.9 million in 2021 define the central range for EBT.
  • Biggest five-year swings in EBT: soared 1898.2% in 2021 and later tumbled 29630.23% in 2024.
  • Year by year, EBT stood at $34.5 million in 2021, then tumbled by 1978.57% to -$648.0 million in 2022, then skyrocketed by 95.09% to -$31.8 million in 2023, then crashed by 485.0% to -$186.1 million in 2024, then soared by 42.56% to -$106.9 million in 2025.
  • Business Quant data shows EBT for CTEV at -$106.9 million in Q4 2025, -$93.4 million in Q3 2025, and -$82.9 million in Q2 2025.